Robust prediction of pan-cancer immune checkpoint blockade response using machine learning

被引：0
|
作者：
Chang, Tiangen
Dhruba, Saugato R.
Cao, Yingying
Morris, Luc G.
Ruppin, Eytan
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-5390
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5390
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Association of KDR mutation with better clinical outcomes in pan-cancer for immune checkpoint inhibitors
    Cui, Yanan
    Zhang, Pengpeng
    Liang, Xiao
    Xu, Jiali
    Liu, Xinyin
    Wu, Yuemin
    Zhang, Junling
    Wang, Wei
    Zhang, Fang
    Guo, Renhua
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (04): : 1766 - +
  • [42] A pan-cancer analysis of GRIN2A as a potential biomarker for immune checkpoint therapy
    Jiang, Mei
    Zhong, Xuefeng
    Huang, Mengli
    CANCER RESEARCH, 2022, 82 (12)
  • [43] GPR65 as a potential immune checkpoint regulates the immune microenvironment according to pan-cancer analysis
    Wang, Liangliang
    Sun, Lele
    Sun, Hao
    Xing, Yunhong
    Zhou, Shidong
    An, Guoshuai
    Li, Jian
    Ren, Kang
    Sun, Junhong
    HELIYON, 2023, 9 (02)
  • [44] Mutation of lysine-specific demethylase 5 is associated with enhanced tumor immunity and favorable outcomes in pan-cancer immune checkpoint blockade
    Li, Xiaofeng
    Zhang, Zhishan
    Li, Yingying
    Chen, Lijin
    Huang, Yan
    Su, Lijuan
    Xu, Wenjun
    Hong, Yanni
    Li, Jianjiao
    Chen, Mujin
    Yang, Hongkui
    Zhao, Hong
    Zhao, Bin
    MOLECULAR CANCER, 2024, 23 (01)
  • [45] The lymphocyte stability index (LSI) forms a pan-cancer peripheral biomarker for overall survival post initiation of immune checkpoint blockade (ICB)
    Watson, R. A.
    Tong, O.
    Taylor, C.
    Vallance, G.
    Santo, F. Matos
    Little, M.
    Sun, B.
    Shine, B.
    Middleton, M. R.
    Coupe, N. A.
    Payne, M.
    Fairfax, B. P.
    ANNALS OF ONCOLOGY, 2023, 34 : S235 - S235
  • [46] The role of YAP1 in survival prediction, immune modulation, and drug response: A pan-cancer perspective
    Hu, Xueqing
    Zhang, Yingru
    Yu, Hao
    Zhao, Yiyang
    Sun, Xiaoting
    Li, Qi
    Wang, Yan
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [47] THE EFFECT OF GUT MICROBIOTA ON IMMUNE CHECKPOINT INHIBITORS IN THE TREATMENT OF PAN-CANCER AND NOVEL MICROBIAL BIOMARKERS FOR PREDICTING THERAPEUTIC RESPONSE
    Lin, Yufeng
    Xie, Mingxu
    Lau, Harry C.
    Wang, Luyao
    Li, Qing
    Chen, Danyu
    Jiang, Lanping
    Yu, Jun
    GASTROENTEROLOGY, 2024, 166 (05) : S171 - S171
  • [48] Machine Learning for Prediction of Survival Outcomes with Immune-Checkpoint Inhibitors in Urothelial Cancer
    Abuhelwa, Ahmad Y.
    Kichenadasse, Ganessan
    McKinnon, Ross A.
    Rowland, Andrew
    Hopkins, Ashley M.
    Sorich, Michael J.
    CANCERS, 2021, 13 (09)
  • [49] Novel genomic signature predictive of response to immune checkpoint blockade: A pan-cancer analysis from project Genomics Evidence Neo-plasia Information Exchange (GENIE)
    Swami, Nishwant
    Hwang, William L.
    Guo, Jimmy A.
    Hoffman, Hannah
    Abramowitz, Matthew C.
    Elbakouny, Ziad
    Beltran, Himisha
    Chipidza, Fallon
    Choueiri, Toni
    Dal Pra, Alan
    Huang, Franklin
    Kaochar, Salma
    Kantoff, Philip
    Kim, Daniel W.
    Kishan, Amar U.
    Kobetz, Erin
    Marinac, Catherine
    Mucci, Lorelei A.
    Muralidhar, Vinayak
    Pollack, Alan
    Sanford, Nina N.
    Schaeffer, Edward M.
    Spratt, Daniel E.
    Zhao, Shuang G.
    Rebbeck, Timothy R.
    Nguyen, Paul L.
    Feng, Felix Y.
    Mahal, Brandon A.
    Alshalalfa, Mohammed
    CANCER GENETICS, 2021, 258 : 61 - 68
  • [50] Machine learning for pan-cancer classification based on RNA sequencing data
    Stancl, Paula
    Karlic, Rosa
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2023, 10
12345